On Thursday, MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) said it submitted an Investigational New Drug (IND) application to the FDA to start human trials for Ketamir-2, its novel oral ketamine analog for ...
The long-awaited overhaul of Mira Mesa Community Park will begin this summer, promising to deliver in two years time an aquatic center, a skate park, a renovated recreation building and substantial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results